Navigation Links
Study shows probiotic Lactobacillus reuteri NCIMB 30242 significantly increased vitamin D levels
Date:6/19/2013

Montreal, June 19, 2013 A study published in the Journal of Clinical Endocrinology & Metabolism is the first report of an oral probiotic supplement significantly increasing circulating vitamin D levels in the blood.

The lead author on the study, Mitchell Jones, MD, PhD, received the Early Career Investigator Poster Presentation Prize from the New York Academy of Sciences and the Sackler Institute for Nutrition Science at last week's Probiotics, Prebiotics, and the Host Microbiome: The Science of Translation conference in New York City(1).

The study(2) , a post-hoc analysis of a published randomized controlled trial, examined the effect of Lactobacillus reuteri NCIMB 30242 on fat-soluble vitamins. It showed that L. reuteri NCIMB 30242 increased circulating 25-hydroxyvitamin D levels by 25.5 percent in hypercholesterolemic adults over the nine-week intervention.

According to the National Institutes of Health, serum concentration of 25-hydroxyvitamin D is the best indicator of vitamin D status, and is important for adequate bone and overall health in healthy individuals(3). More than 40 million adults in the United States have or are at risk of developing osteoporosis, a disease most often associated with inadequate calcium intake. Insufficient vitamin D contributes to osteoporosis by reducing calcium absorption(4) . Researchers continue to study other possible health effects of vitamin D, such as protection against heart disease, autoimmune diseases, and diabetes.

The Institute of Medicine recommends 600 IUs of vitamin D daily to meet the needs of almost everyone in the United States and Canada. Most people get vitamin D through sun exposure, foods that contain it, and supplements. A variety of factors may reduce vitamin D absorption, including limited exposure to sunlight, dark skin, obesity, and problems with absorption or ability to convert vitamin D to its active form.

"This study, part of an ongoing line of research in bile metabolism and Western disease, is adding to the body of knowledge on the microbiome and its role in human health," said Dr. Jones, lead study author and chief scientific officer, Micropharma Limited. "Although it has long been known that the gastrointestinal tract plays an active role in the absorption of vitamin D, these findings showing improved vitamin D status in response to an orally delivered probiotic are a first, and will inform the development of new products that may be beneficial for people with low vitamin D levels."

Previous studies have shown the effect of L. reuteri NCIMB 30242 on cholesterol reduction, but its effect on the absorption of fat-soluble vitamins was unknown.

"The vitamin D market has grown by 20 percent a year over the last 10 years, and within this timeframe, U.S. medical costs around osteoporosis and fractures in an aging population were already estimated at $22 billion(5)," said Ryan Jones, Micropharma's chief executive officer. "As a pioneer in research and innovation on products that work naturally through the microbiome to impact health outcomes, we are very encouraged about the potential for these vitamin D findings for public health."


'/>"/>

Contact: Laura Muma
lmuma@foodminds.com
773-960-3960
FoodMinds LLC
Source:Eurekalert

Related biology news :

1. Scientists use DNA from a museum specimen to study rarely observed type of killer whale
2. Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds
3. Study of oceans past raises worries about their future
4. Study helps managers identify regions with multiple threat potential, including wildfires
5. Dads life stress exposure can affect offspring brain development, Penn Study finds
6. NIH awards UCI $10 million to study early-life origins of adolescent mental disorders
7. New Loyola study on hepatitis C virus entry factor
8. Biofuels will play integral role in Californias energy future, says new EBI study
9. New study proposes solution to long-running debate as to how stable the Earth system is
10. Study finds disincentives to energy efficiency can be fixed
11. Study finds taking probiotics has benefits for patients in hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
(Date:1/22/2016)... , January 22, 2016 /PRNewswire/ ... announced the addition of the  "Global ... their offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... ... February 11, 2016 , ... Reichert Technologies, which ... today to pursue the highest level of accuracy and quality with the addition ... and the AR5 Refractometer. Accurate, reliable and tough enough for the most ...
(Date:2/10/2016)... BioAmber Inc. (NYSE: BIOA ), a leader in ... Co. Ltd., its partner in the Sarnia ... additional CDN$25 million in the joint venture for 10% ... 40%.  Mitsui will also play a stronger role in ... Sarnia , providing dedicated resources alongside BioAmber,s commercial ...
(Date:2/10/2016)... , Feb. 10, 2016 NX Prenatal Inc., ... proprietary NeXosome® technology for early warning of adverse ... most recent study by Dr. Thomas McElrath ... Society for Maternal Fetal Medicine,s (SMFM) annual meeting held ... th , 2016.  The presentation reported initial positive ...
(Date:2/10/2016)... (NYSE MKT: ISR), a medical technology company and innovator ... treatment of prostate, brain, lung, head and neck and ... second quarter and six months of fiscal 2016, which ... --> Revenue was $1.19 million for ... 31, 2015, a 12% increase compared to $1.07 million ...
Breaking Biology Technology: